America Bio Medica gets supply deal for drug tests:
This article was originally published in Clinica
America Bio Medica is to supply 13,000 drug tests each month to a Louisiana-based organisation that provides workplace drug testing to more than 7,000 businesses in south-east US. The deal represents annual sales in excess of $1 million. America Bio Medica is an early-stage biomedical company which develops and markets rapid drugs-of-abuse kits as well as other biomedical technologies and devices. The company claims its drug detection strip is 100% sensitive to substances of abuse.
You may also be interested in...
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.